ABOUT THE PRODUCT
The Derisq™ AI report accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. This report utilizes GATC Health’s AI platform to provide critical insights for risk mitigation.
Information is owner-confirmed
Last updated 1 month ago
Price range
Other products/services from GATC Health
Operon™ platform
Biotechnology
N/A
GATC Health
United States (US)